• Data gathered through ShieldSaver’s proprietary license-plate recognition technology is applicable for repairs, maintenance, insurance, purchasing, parts and more
• New ShieldSaver app allows consumers to connect, source and schedule windshield repairs quickly and at reduced cost
• The automotive glass industry was estimated at $12 billion in 2017; it’s expected to grow at a CAGR of 7 percent until 2024

SinglePoint Inc. (OTCQB: SING) continues to bolster its reputation as a diversified tech holding company with operations in multiple industries and verticals with astute acquisitions and investments. Subsidiary ShieldSaver, acquired in 2018, opens SinglePoint’s portfolio to the multibillion-dollar automotive repair and maintenance industry (http://ibn.fm/EsfSC). The significance of ShieldSaver’s proprietary license-plate recognition technology, which gathers data on both cars and consumers, is considerable, since the data has value far beyond the obvious, as a NetworkNewsAudio publication explains (http://ibn.fm/3iYdI).

The most apparent use is to identify when repairs are needed and then approach car owners about getting the work done, but the data also has value to other stakeholders (http://ibn.fm/KOhU5), such as insurance companies, parking-lot owners, parts suppliers and people buying cars, as it can give them a better understanding of both individual vehicles and the bigger picture. Efficient repair and maintenance work can have valuable knock-on effects, according to an NNW editorial (http://ibn.fm/ZXeSE) titled ‘Data and Connectivity Take Center Stage in Changing World of Automobile Technology’.

The automotive glass market exceeded $12 billion in 2017 and is expected to grow at a compound annual growth rate of 7 percent until 2024 (http://ibn.fm/lv0Vy). Increased vehicle production and sales, novel safety regulations and the demand for advanced glass technologies (smart glass, for example) are all projected to contribute to the massive growth (http://ibn.fm/56uqf).

SinglePoint’s new ShieldSaver app (http://ibn.fm/Sl8Z5) allows people to connect to ShieldSaver’s services directly from their phones, so that they can source and schedule windshield repairs quickly and at reduced cost. ShieldSaver has also developed strategic partnerships with some big names within the sector, including Mygrant Glass, Wally Park, LAZ Parking and others.

“With the new application SinglePoint led in developing over the past year, we have started to grab a lot of attention,” Dan Shikiar, founder of ShieldSaver, said in the NNW editorial. “Opportunities have started to pile up after our first showcase – people who see the ShieldSaver platform absolutely love it. We feel this market is underserved and is ripe for new technologies to streamline for customers and providers.”

SinglePoint specializes in the acquisition of small and mid-sized companies that operate in new technological fields. These acquisitions provide opportunities for investment across a wide range of assets, including payment solutions, cannabis brands, blockchain technology developers and more. Through acquisitions into horizontal markets, SinglePoint is building a solid portfolio that ensures a rich and diversified holding base.

For more information, visit the company’s website at www.SinglePoint.com

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

• 2018 major milestones included launch of medicinal and recreational sales channels
• Company sold nearly 406 kilograms of premium cannabis, despite having only 20 percent of Kelowna 1 grow rooms operational during Q4 2018
• Flowr optimizes yields, producing premium and ultra-premium cannabis products with a goal of no irradiation, to maximize profitability

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Canadian licensed producer of premium cannabis products, recently shared details of several milestones achieved during the fourth quarter of 2018 that included the company’s first recorded revenues, with nearly 260 kilograms of premium cannabis grown in-house during the period, despite only 20 percent of its facility being operational. Flowr Co-CEO Vinay Tolia noted the significance of the sale as he addressed shareholders during an April 4 conference call.

“The fourth quarter of 2018 marked a major milestone for Flowr, as we launched our medicinal and recreational sales channels after receiving our licenses in August 2018, and sold nearly 406 kilograms of premium cannabis, despite having only 20% of our grow rooms in Kelowna 1 operational during the quarter itself,” Tolia said in a news release (http://ibn.fm/eI6Cb).

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to consistently generate high crop yields of premium and ultra-premium cannabis products. Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to meet pharmaceutical industry production standards for cleanliness without resorting to the taste- and smell-killing gamma irradiation that most other licensed producers use to clean their product (http://ibn.fm/Rmyoh).

Flowr currently has 10 grow rooms in Kelowna 1 licensed for use, with eight rooms propagated with plants, and expects to have all 20 grow rooms fully constructed by the end of the third quarter of 2019. Completion of Kelowna 1 should enable the company to begin capitalizing on strategic growth opportunities for medicinal and recreational use, with approximately 10,000 kilograms of capacity for premium cannabis flower on an annualized basis.

“As a global leader in the premium cannabis industry, our design and cultivation expertise along with our superior IP know-how enables us to grow high quality cannabis on a large scale at what we believe will be industry-leading yields,” Tolia emphasized in a news release. “The revenue numbers reflect our ability to grow and process high quality product with only a fraction of our facility and packaging area complete. Once our Kelowna 1 facility is completed in Q3 2019, our operational efficiency will only improve.”

Flowr also plans to expand its product line by selling a selection of its premium, high-quality cannabis in clone and seed form to customers both at home and abroad. Company Co-CEO Tom Flow announced the venture in an earlier news release (http://ibn.fm/yzT78), calling the move “an exciting and potentially very big market for Flowr that is a natural extension of our high-yield, high-quality approach to cultivation.”

“Growing great cannabis starts with great genetics and clean healthy plants, something few companies are able to provide,” Flow stated in the release. “As we ramp up production, we believe Flowr will be able to offer the select cultivars we use to produce our premium cannabis to cultivators globally.”

According to Stratistics MRC, the global cannabis market accounted for $10.39 billion in 2017 sales and is expected to reach $154.82 billion by 2026, growing at a compound annual growth rate of 35 percent during the forecast period. Some of the key factors propelling the market growth are the medicinal properties of cannabis, increasing legalization of cannabis and advances in genetic development and intellectual property related to cannabis (http://ibn.fm/w6eed).

For more information, visit the company’s website at www.Flowr.ca

NOTE TO INVESTORS: The latest news and updates relating to FLPWF are available in the company’s newsroom at http://ibn.fm/FLWPF

• A majority of Canadian cannabis users identified quality and safety as top factors in choosing where to purchase cannabis
• Canada’s Shoppers Drug Mart is now the exclusive direct-to-patient online provider of FlowrRx products
• Flowr grows premium cannabis with a goal of non-irradiation using production methods that are expected to generate high crop yields at low operating costs

Medicinal cannabis patients in Canada are rightly concerned about how cannabis products prescribed by their physicians are produced. According to Canada’s national statistical agency, Statistics Canada, 76 percent of medical cannabis patients responding to the Q4 2018 ‘National Cannabis Survey’ identified quality and safety as the top factors used in their decision-making process when choosing where to fill their prescriptions (http://ibn.fm/yRfzw).

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Canadian licensed producer of premium cannabis products, cultivates its cannabis in a purpose-built facility with controlled environments engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. Control over cultivation and innovative practices result in a cost-efficient cultivation process. As the company notes, high yields per square foot are key to ensuring low operating costs and profitability.

Flowr aims to avoid irradiating its final product, something that approximately 80 percent of other cannabis companies do, according to Cannabis Tech (http://ibn.fm/gRISH). Flowr’s commitment to delivering a clean cannabis product that meets Health Canada’s strict testing requirements with a goal of no irradiation sets it apart, as CEO Vinay Tolia explained in a podcast (http://ibn.fm/ieuOV), noting that “the plant needs a lot of TLC.”

Medical cannabis patients can now purchase Flowr’s premium FlowrRx products through the Shoppers Drug Mart online medical cannabis platform, as the company recently announced in a news release (http://ibn.fm/juq7F). This direct-to-patient distribution agreement with Shoppers Drug Mart provides medical cannabis patients with several options.

“Flowr’s premium medical cannabis is grown in what we believe is the industry’s most advanced GMP designed cultivation facility. This relationship is testament to our commitment to ultra-high-quality cannabis cultivation and further solidifies Flowr’s role in Canada’s medical cannabis landscape,” Tolia said in the news release.

Canada opened up recreational cannabis to adult users in October 2018 and has since released new regulations governing cannabis-infused edibles and beverages, along with cannabis concentrates, which are set to be legalized in mid-October 2019. According to Stratistics MRC, the global cannabis market accounted for $10.39 billion in 2017 sales and is expected to reach $154.82 billion by 2026, growing at a compound annual growth rate of 35 percent during the forecast period (http://ibn.fm/bpoFd).

For more information, visit the company’s website at www.Flowr.ca

NOTE TO INVESTORS: The latest news and updates relating to FLPWF are available in the company’s newsroom at http://ibn.fm/FLWPF

• Sustainable growth in revenue mainly stemmed from the North American transaction solutions segment
• The total processing volume also grew to reach $3.3 billion, most of which was covered by North America
• Net Element subsidiaries like Aptito have been contributing to the U.S. market growth with the provision of cost-efficient, tailored and innovative niche services

Net Element Inc. (NASDAQ: NETE) recently announced solid financial growth in 2018. The company’s revenue over the year went up to $65.8 million, marking an increase of 10 percent on an annual basis. Growth through the company’s North American transaction solutions segment was the primary driver for the strong results, as the company’s management announced in an earnings conference call on April 2, 2019 (http://ibn.fm/ZfEls).

The North American transaction solutions segment experienced annual growth of 16 percent in 2018. The United States accounted for 90 percent of the overall revenue, while international revenue contributed 10 percent.

In 2018, the company’s total processing volume reached $3.3 billion – an increase of 18 percent in comparison to 2017 figures. North America accounted for $2.9 billion, marking an increase of 27 percent as compared to the previous year.

According to Net Element’s management team, the North American transaction solutions segment also showed positive trends in terms of development and acquisitions. During 2018, the company acquired recurring cash flow portfolios from sales partners that are anticipated to contribute to over $9 million in gross profit over the coming four years.

The payment industry is evolving rapidly due to new technologies and changing customer needs. These market dynamics create opportunities for companies like Net Element and its subsidiaries.

Under wholly owned subsidiary Aptito, for example, Net Element provides complete business management solutions and cloud-based POS for the restaurant industry (http://ibn.fm/EYbbH). Such innovative solutions are a good choice for both large businesses and small restaurants or startups in the industry attempting to establish market position on limited budgets.

Aptito has developed a range of payment solutions tailored to the needs of various clients in the restaurant industry. These include Aptito POS, mPOS (http://ibn.fm/hib83), kiosks and digital menus. This integrated product range is favored over competitive solutions due to cost-efficiency, ease of use, simplified inventory management, improved scheduling and payroll management and cloud-enabled functionality.

The restaurant niche is characterized by rapid growth and ever-changing trends. Currently, it generates four percent of the U.S. GDP and employs more than 15 million people (http://ibn.fm/Qu20w). Due to this rapid industry growth, restaurants have to work hard to maintain competitive advantage through cost-efficient solutions and services that enable the enhancement of client satisfaction levels.

Net Element is a global financial technology and value-added solutions group that supports electronic payment acceptance in an omni-channel environment. It operates a payment-as-a-service transactional model and value-added services platform for small and medium enterprises.

In 2018, Net Element was named one of the top 10 retail payment service companies by Retail CEO Outlook. The selection of the best service providers is made on the basis of the delivery of time-focused, effective and economic payment solutions and services.

For more information, visit the company’s website at www.NetElement.com

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE

• Vaping is growing in popularity in the United States and internationally, driving cannabis concentrate sales toward a forecast reach of $47.11 billion by 2025
• VPR Brands has built on the successful acquisition of Vapor Corp. technologies and has recently been growing into the cannabidiol (CBD) derivatives space
• VPR Brands’ GoldLine Hemp products are also finding a niche in the convenience store market as a variety of CBD-free hemp edibles

Vaporizers and e-cigarettes have been enjoying growing popularity in recent years, becoming the largest driver behind cannabis concentrate sales and maintaining a position as the second-largest marijuana product category in the United States (http://ibn.fm/TYH3P). Meanwhile, a burgeoning international market has begun to take shape as a new field for commerce. Innovative technology holding company VPR Brands, LP (OTC: VPRB), whose assets include patented atomization-related products and technology, is building on the expanding opportunities with a variety of products aimed at conscientious vape consumers.

Analysts at Research and Markets foresee growth in the global vaping tank market, calling for a CAGR of 28.92 percent between 2019 and 2023 (http://ibn.fm/IKRxX). Grand View Research predicts a similar 23.8 percent CAGR between 2018 and 2025, culminating in sales of $47.11 billion (http://ibn.fm/upFuU).

VPR Brands has enjoyed steady growth in sales since acquiring Vapor Corp. in 2016, thanks to a product base that includes premium open tank mod Honey Stick – the first lifestyle brand to market to offer a ceramic sub-ohm vaporizer that’s available in three different sizes. Sub-ohm vaporizers have become popular with consumers looking for a stronger straight-to-lung vapor or flavor thanks to their low-resistance, higher-wattage output mechanics (http://ibn.fm/WHm6C).

In addition to the Honey Stick, VPR Brands’ technology is making premium cannabis concentrate vaporizers available to white label customers through its private label program. Its portfolio of brands also includes high definition Helium e-liquid, which is sent in vaping chillers that are scientifically proven to preserve flavor, freshness and aroma by utilizing a squeezable bottle with a drip tip that’s engineered to deliver 77 percent vegetable glycerin, as well as Vaporin, another vaporizer brand in VPR’s portfolio that was recently launched as a convenience friendly sub-ohm series of starter kits. All of these are available through Vapor Store Direct, one of VPR’s websites that is dedicated to serving e-liquid wholesalers in the United States with internationally elite brands and a strong suite of restock supplies.

In recent months, VPR Brands has also successfully entered the cannabidiol-derived products market with brands such as GoldLine’s Gummies And Pure Honey Stix, tinctures, pre-rolled flower, vapable products and creams; GoldLine Hemp’s CBD-free hemp edibles developed specifically for the convenience store market segment; and VaporX, which combines some of the best off-the-shelf products from brands such as KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech and Samsung to create connoisseur-grade vaporizer kits.

“One of our most notable accomplishments in 2018 was the successful release of our GoldLine product division, which sells cannabidiol (CBD),” CEO Kevin Frija informed shareholders in a December news release. “Our GoldLine product division is not only a good parallel to our vape portfolio, but also gives us exposure within the consumable supplements and nutraceuticals sectors, greatly increasing our target markets and potential customers. We believe that the repeat business frequency in these sectors adds an exponential factor into our growth equation… We expect to continue to add to our product line, while also increasing our supply to meet growing demand.”

The company launched its international sales efforts in 2017, with plans to headquarter Director of International Sales Ezequiel Pavlotsky in the European Union this year so that he can best represent the company and build relationships with distributors in the region’s varied countries. Frija said that VPR Brands had almost completed the required testing and certification to allow all of the company’s products to be imported and sold in the EU at the time.

For more information, visit the company’s website at www.VPRBrands.com

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://ibn.fm/VPRB

• Trxade Group, an integrated pharmaceutical services company, recently announced positive financial results for the year ended December 31, 2018
• Revenue from the Trxade market platform grew 16 percent in 2018, reaching $3.4 million from $2.93 million in 2017
• Trxade has also announced plans to continue expanding its range of services, as well as the network of independent pharmacists reliant on the Trxade B2B platform

Financial results show that 2018 was a successful year of growth for Trxade Group Inc. (OTCQB: TRXD), an integrated drug purchasing and delivery solutions company with a platform that enhances supply chain efficiencies among health care buyers and sellers of pharmaceuticals, accessories and services. The company recently presented its report for the final quarter of 2018, highlighting a number of key accomplishments (http://ibn.fm/tPpOh).

Revenue from the Trxade market platform operations reached $3.4 million in 2018 – an increase of 16 percent on an annual basis. Revenue from Community Specialty Pharmacy, a company acquired by Trxade in 2018, reached $395,418 in the final quarter of 2018, the report shows.

The company achieved a number of important milestones over the past year. The acquisition of Community Specialty Pharmacy was one of the biggest highlights. Community Specialty Pharmacy LLC was incorporated in 2010, carving a niche in the competitive independent pharmacy field through a patient-driven approach. As a specialty pharmacy, the company can provide niche health care solutions to patients dealing with an array of chronic conditions.

Trxade has announced plans to continue working on its expansion and has already taken steps in this direction. At the end of February 2019, Trxade Group launched its MSO pharmacy network via a SyncHealth joint venture (http://ibn.fm/X5Obz). In addition, the Trxade network of validated independent retail pharmacies surpassed 10,000 members at the beginning of the year. This figure accounts for nearly 30 percent of U.S. independent pharmacists that purchase prescription drugs through the Trxade B2B platform.

Through the use of innovative technologies and industry services, Trxade Managed Services Organization (“Trxade MSO”) enables members of the network to improve patient care by best servicing physician orders utilizing an efficient patient-centric process. Through the use of the Trxade MSO artificial intelligence software, pharmacists can both predefine and monitor best-suited services that are relevant to the specific needs of the patient.

In addition, the software enables pharmacists to ensure appropriate medication coverage on the basis of location, payor coverage, medication access, inventory and custom services. These solutions allow pharmacists to enhance patient care by adopting a customer-centric approach and promoting improved workflow management, reporting and fulfillment.

Trxade continues working to improve Trxade MSO’s features. A few of the upgrades anticipated in the future include the integration of telemedicine and the introduction of an Rx Manager. The second functionality will allow for easier script management by clinicians.

Trxade Group is a leader in the realm of pharmaceutical e-commerce marketplaces. The company’s platform enables thousands of independent pharmacists to access low-cost medication from a wide range of wholesale distributors. The proprietary patient-centric E-HUB technology and the Trxade affiliate channel partnerships enable the provision of workflow technology solutions for the generation of new independent pharmacist business.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company’s newsroom at http://ibn.fm/TRXD

• GCGX is a diversified cannabis holding company with $100 million in projected revenue for 2019
• The company’s nutraceuticals division is to be overseen by medical physicians and veterinarians focused on diverse specialties
• GCGX’s product line is developed with proprietary infused formulas to include lotions, balms, ointments, liquids, pills and powders
• Discussions are underway to take one of the company’s divisions public in Canada in order to raise capital and open up growth potential

From its headquarters in Florida, Global Consortium Inc. (OTC: GCGX), a diversified cannabis holding company expanding its reach nationwide with several subsidiaries, is evaluating an opportunity to take one of its divisions public in Canada. Cannabis businesses listed in Canada have historically thrived after going public on the Canadian Stock Exchange (“CSE”), which also allows firms to dual list in the United States, as the company noted in a news release (http://ibn.fm/qmT6F).

The benefits of taking one of Global Consortium’s divisions public on the CSE include the possibility of receiving a higher multiple and potentially gaining easier access to capital for expansion, as the news release states. The Canadian government’s passage of the Cannabis Act, legalizing adult-use recreational cannabis in October 2018, included a provision allowing the sale of cannabis edibles, extracts and topicals once regulations were created. Sales of edibles, oils, topicals and other infused products are now expected to be legal in Canada by mid-October 2019, according to an article published by Forbes (http://ibn.fm/m9VI3).

Global Consortium’s decision to add a medical-grade nutraceutical division under its Infused Edibles subsidiary (http://ibn.fm/doSOa) is therefore well-timed, with the first tested products expected to reach market by June 2019 (http://ibn.fm/JaxXn). The nutraceutical division is expected to be overseen by medical doctors and veterinarians from different specialties, ensuring that every proprietary formula is designed with a holistic approach for human or animal use.

Each new formula will be compounded and tested by a lab in California prior to being made available to the public, per company announcements. The nutraceutical line will likely consist of lotions, balms, ointments, liquids, pills and powders, with some of the formulations marketed to medical practices as “white labeled,” which allows products to be custom-tailored.

Global Consortium’s Cannabis Mall, which is currently under construction in the Sacramento, California, area, is designed to house cannabis manufacturing, distribution, delivery, retail, testing and cultivation – all under one 64,000-square-foot building that showcases various cannabis operations ranging from seed to shelf. The company stated on its Twitter feed on April 8 (http://ibn.fm/oVMTi) that it will soon be taking delivery of a machine capable of processing 600 pounds of product every eight hours, producing around 23 liters of oil per day at a forecast minimum of $8,000 per liter for large contract orders. The Cannabis Mall will aim to showcase various cannabis operations, such as processing cannabis extractions.

Global Consortium has acquired several companies in the cannabis space, with several subsidiaries, partnerships and licensing agreements. Among its assets are the award-winning Infused Edibles product line; premium medical marijuana oils provider Infused Oils; and CO Hemp, a licensed 600-acre hemp farm in Colorado.

For more information, visit the company’s website at www.GCGX.org

NOTE TO INVESTORS: The latest news and updates relating to GCGX are available in the company’s newsroom at http://ibn.fm/GCGX

• Kontrol Energy Corp. specializes in disruptive technology acquisitions that focus on energy use applications
• The company has expanded its reach from facilities management to automotive industry productivity and cannabis farm emissions control
• Amid Canada’s developing governmental regulations in the wake of nationwide cannabis legalization, cultivators are facing complaints about their environmental impact
• The market for global industrial emissions control is expected to grow, with a forecast CAGR of 7.8 percent through 2024 and sales of $21.1 billion by 2022

Efforts to “save the planet” have for decades turned worries about changes in our natural environment into a variety of climate-friendly endeavors, once leading comedian George Carlin to complain, “Save the planet?! We don’t even know how to take care of ourselves yet!” Smart energy efficiency platform developer Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is helping businesses take care of themselves and care for their neighbors while making the earth’s climate a little friendlier for humanity in the process.

Kontrol Energy is a Canadian company focused on developing market-disrupting digital technologies, specifically working to help customers reduce their overall energy-consumption costs while establishing a corresponding reduction of their greenhouse gas (GHG) emissions.

Initially intent on helping building managers monitor, assess and control electrical usage in their facilities, Kontrol’s functionality has grown from acquiring companies in the sector encompassing building automation systems, although that part of its mission continues, with its seventh acquisition currently pending, as announced on March 14, in support of the goal of adopting further electrical efficiency retrofit services (http://ibn.fm/P31c8).

The company announced recently that it will be working with Toyota Tsusho Canada, Inc. (“TTCI”) in a joint venture aimed at applying its digitized, real-time data analysis and machine learning capabilities toward real-time energy management in the automotive industry, providing technological solutions and services to Original Equipment Manufacturer (OEM) clients to help them get the most efficiency from their production operations (http://ibn.fm/BQS8I).

Kontrol followed that announcement with a news release on April 1 stating that the company will be advising cannabis industry clients in Canada on analysis of their emissions as government regulations continue to coalesce in the wake of the nation’s legalization of full adult-use options for the drug last year (http://ibn.fm/aVIfd).

“We offer turn-key odour and emission services designed to scientifically identify, measure and mitigate VOCs (volatile organic compounds) and help our customers be at the leading edge of compliance. We can assess applicable odour control technologies such as carbon filtration, ionization, etc. and then provide the turn-key technology solution and other critical systems required that are best suited for the specific facility,” Kontrol Energy CEO Paul Ghezzi stated in a news release. “Further, solutions to continuously monitor the effectiveness of odour control equipment or the ambient air outside of the facility can be the early warning system required to reduce the frequency of odour complaints. We are well positioned to add new customers in the Cannabis industry and grow our footprint in this significant new market.”

Elevated VOC levels can be produced during the cannabis plant flowering and harvesting process. Kontrol Energy and its operating subsidiary, ORTECH Consulting, have more than 40 years of history working with issues surrounding emissions in multiple industry sectors, according to the company.

Analysts at Research and Markets predict that the global industrial emission control systems market will grow at a CAGR of 7.8 percent between 2018 and 2024 (http://ibn.fm/1NPZ6). Allied Market Research foresees the sector reaching $21.1 billion in sales by 2022 (http://ibn.fm/nSnxo). The cannabis industry clearly has a role to play in the global emissions trends, as cultivators are being hit with a growing incidence of complaints over their environmental impact (http://ibn.fm/oyxNy). Kontrol Energy is aiming to help those growers be good corporate citizens.

For more information, visit the company’s website at www.KontrolEnergy.com

NOTE TO INVESTORS: The latest news and updates relating to KNRLF are available in the company’s newsroom at http://ibn.fm/KNRLF

• Company plans to enter the cannabis edible and beverage markets
• CVGR recently entered into a partnership with a leading Jamaican Blue Mountain coffee company
• Company has appointed an alcohol beverage industry veteran as its new CEO

Focused on seed-to-retail, City View Green Holdings Inc. (CSE: CVGR) is a vertically integrated cannabis company whose primary objective is to diversify, with an aim of assessing and potentially acquiring targets in the cannabis industry. Once the company has acquired its Cannabis Act license, its plans include the production of high-quality edible products, distillates and water-soluble products for domestic and international CBD-infused beverage markets. The company will incorporate growing, extraction, production and retail operations at its 40,000-square-foot facility in Brantford, Ontario.

City View Green has entered into a partnership with Blue Bean Coffee Ltd., a global representative of the leading Jamaican Blue Mountain coffee farms (http://ibn.fm/hQcvN). Coffee has the potential to play a large role in the edible and consumable cannabis space, and CVGR wanted to partner with Blue Bean Coffee because of the company’s focus on delivering the finest tasting and highest quality coffee products possible.

Five coffee farms with boutique roasting capability make up the network of Blue Bean Coffee’s suppliers, which are nestled in the highest elevations of the Blue Mountains. Only the finest handpicked beans are selected, ensuring that each cup delivers the highest quality of aroma and taste. The goal is to develop and provide the highest-quality and best-tasting THC- and/or CBD-infused coffee in the industry.

In addition to this partnership, CVGR is assembling a highly qualified management team with extensive contacts that will set the company apart from the competition. CVGR’s new CEO, Ian MacDonald, brings with him proven leadership in the international alcohol beverage industry. MacDonald has repeatedly transformed companies in the alcohol beverage space into award-winning, industry-leading organizations.

MacDonald did not come to City View Green lightly. Before making the move, he spent time with the organization to ensure that it was equipped to deliver the type of success toward which he works. Only after meeting the CVGR team, vetting the business model and assessing the company’s ability to differentiate itself from the competition did MacDonald agree to join the team.

“City View Green has arguably the best team in the business,” MacDonald said in a news release when asked what sets the company apart in the cannabis industry. “Our master grower is a former founder of Weed MD, our extraction specialist is one of the most experienced extraction professionals in North America, our QA person has actual cannabis experience, which is rare in a market that is still in its infancy. It’s the team that will set us apart from everyone else.”

Rob Fia, who has led the company from concept to realization, will step down as CEO of CVGR and will be appointed president, working alongside MacDonald to take the company to the next level (http://ibn.fm/S5OiE).

For more information, visit the company’s website at www.CityViewGreen.ca

NOTE TO INVESTORS: The latest news and updates relating to CVGR are available in the company’s newsroom at http://ibn.fm/CVGR

• Offers a proprietary web-based platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services
• Significant first-mover advantage over competitors operating similar e-commerce platforms
• Targeting the 24,000 U.S. independent pharmacies with combined pharmaceutical purchases of $93 billion per year
• Currently adding 100+ pharmacies per month to the TRxADE platform
• Revenue growth driven by increases in the number of registered users and increase in utilization rate of the trading platform

Trxade Group Inc. (OTCQB: TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.Trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

• Increase share of pharmacist drug purchasing
• Additional SKUs and expand product breath
• Partner with Specialty and International Mfg.
• Expand mail order licenses to all 50 states
• Scale Delivmeds for consumer delivery nationwide
• Integration with telemedicine
• M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade’s overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company’s pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the “consumer side” of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called “Delivmeds” (www.Delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade’s Managed Services Organization (“TrxadeMSO”) enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient’s information, thereby ensuring appropriate medication coverage based on the patient’s location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market 

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade’s fair online market platform targets the nation’s retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE’s programs include:

• TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
• RX Guru is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks (“PAC”) to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
• Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE’s advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.

Management Team 

Trxade’s management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade’s chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade’s full-time president and COO, and as a director since the company’s acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company’s newsroom at http://ibn.fm/TRXD